Array BioPharma Inc. Security Rating

Unclaimed

Industry Manufacturing
Footprint 533.1K IPs
Followers Monitored by 6 companies
Year founded 1998
Employees 110

The Company’s wholly owned clinical stage drugs include Filanesib in Phase II clinical trials, is indicated for Kinesin spindle protein (KSP), inhibitor for MM; ARRY-797 in Phase II clinical trials, indicated for p38 inhibitor for Lamin A/C-related dilated cardiomyopathy (LMNA-DCM); ARRY-502 in Phase II clinical trials, indicated for CRTh2 antagonist for asthma, and ARRY-614 in Phase I clinical trials, is indicated for p38/Tie2 dual inhibitor for myelodysplastic syndromes (MDS). In addition, the Company has 11 ongoing partner-funded clinical programs, including two MEK inhibitors, which are both in Phase III clinical trials, binimetinib with Novartis and selumetinib with AstraZeneca.

90/ 100

Start Free Trial

SecurityScorecard calculates cybersecurity scores based on 10 factors that reflect different cybersecurity practices and risks.

Learn more about our scoring methodology

What do our scores mean?

We learned from over 12 million cybersecurity ratings that companies with an F are 13.8 times more likely to be impacted by a breach versus those with an A.

Visit Our Scorecard

Business prospects want to know that you're maintaining a strong cybersecurity program. Show it off with a free SecurityScorecard badge.

How to use badges

OpenAI may be developing its own social platform but who’s it for?

techcrunch.com

You’re invited to a fireside with Baiju Bhatt on Sand Hill Road on June 18 at StrictlyVC

techcrunch.com

Footprint

issue

factor

grade

SecurityScorecard collects billions of signals each week, helping organizations see risks, get more actionable information, and respond faster to keep up with threat actors. Security teams are able to react quickly to digital criminals, respond to Zero-Day incidents faster, and reduce the risk exposure timeline.

Learn More About Security Signals

These are some of the factors we use to calculate the overall score:

Network Security

Discover open access points, insecure or misconfigured SSL certificates, or database vulnerabilities.

Patching Cadence

Understand how diligently a company is patching its operating systems, services, applications, software, and hardware in a timely manner.

IP Reputation

See the quantity and duration of malware infections, along with other factors influence the overall assessment of an organization’s IP Reputation.

Endpoint Security

Understand the effectiveness of protections in place for laptops, desktops, mobile devices, and all employee devices that access that company’s network.

How is your Scorecard calculated?

Take a look at the 10 factor categories at the core of SecurityScorecard’s cybersecurity rating methodology.

Embed security into your company DNA

Cyber risk ratings influence business activity from the loading dock to the board room. Learn all how to incorporate security ratings insights into workflows throughout your organization

Scorecards deliver real value

How do you quantify cyber risk management? Threat prevention may be hard to compute, but Forrester Consulting has done the work or you. Spoiler alert: SecurityScorecard customers realize investment payback in under a quarter.

11,000,000+ companies rated

Get your free Security Ratings report to see your custom score

Get Free Report

Array BioPharma Inc. Security Rating

SecurityScorecard Badge

Latest news

OpenAI may be developing its own social platform but who’s it for?

You’re invited to a fireside with Baiju Bhatt on Sand Hill Road on June 18 at StrictlyVC

Meta conducts layoffs in Oculus Studios, impacting VR exercise app Supernatural

Parents who lost children to online harms protest outside of Meta’s NYC office

NFC-Powered Android Malware Enables Instant Cash-Outs

Threads officially moves to Threads.com and updates its web app

Others in their industry

What do we measure?

How is your Scorecard calculated?

Embed security into your company DNA

Scorecards deliver real value

Trending Scorecards